Skip to Main Content

Author Details

Amy L Ellis-Connell
University of Wisconsin
2010
25
9
PMIDPaper TitleJournal TitlePublished Year
36909458CD8+ cells and small viral reservoirs facilitate post-ART control of SIV in Mauritian cynomolgus macaques.bioRxiv2023
37747933CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection.PLoS Pathog2023
37616311Mathematical modeling indicates that regulatory inhibition of CD8+ T cell cytotoxicity can limit efficacy of IL-15 immunotherapy in cases of high pre-treatment SIV viral load.PLoS Comput Biol2023
37814073Intravenous Bacille Calmette-Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis.Nat Microbiol2023
37090620Vaccination with intravenous BCG protects macaques with pre-existing SIV infection from tuberculosis.Res Sq2023
37039653Host Immunity to Mycobacterium tuberculosis Infection Is Similar in Simian Immunodeficiency Virus (SIV)-Infected, Antiretroviral Therapy-Treated and SIV-Naïve Juvenile Macaques.Infect Immun2023
36377872Transient T Cell Expansion, Activation, and Proliferation in Therapeutically Vaccinated Simian Immunodeficiency Virus-Positive Macaques Treated with N-803.J Virol2022
35467372Spontaneous Control of SIV Replication Does Not Prevent T Cell Dysregulation and Bacterial Dissemination in Animals Co-Infected with M. tuberculosis.Microbiol Spectr2022
36190256IL-15 Superagonist N-803 Enhances IFN-γ Production of MAIT Cells in SIV<sup>+</sup> Macaques.Infect Immun2022
36190241Control of Simian Immunodeficiency Virus Infection in Prophylactically Vaccinated, Antiretroviral Treatment-Naive Macaques Is Required for the Most Efficacious CD8 T Cell Response during Treatment with the Interleukin-15 Superagonist N-803.J Virol2022
34145063Pre-existing Simian Immunodeficiency Virus Infection Increases Expression of T Cell Markers Associated with Activation during Early <i>Mycobacterium tuberculosis</i> Coinfection and Impairs TNF Responses in Granulomas.J Immunol2021
34066765Monkeying around with MAIT Cells: Studying the Role of MAIT Cells in SIV and Mtb Co-Infection.Viruses2021
34319980Mathematical modeling of N-803 treatment in SIV-infected non-human primates.PLoS Comput Biol2021
32433713MAIT cells are functionally impaired in a Mauritian cynomolgus macaque model of SIV and Mtb co-infection.PLoS Pathog2020
30353260Characterization of major histocompatibility complex-related molecule 1 sequence variants in non-human primates.Immunogenetics2019
31092584CD8β Depletion Does Not Prevent Control of Viral Replication or Protection from Challenge in Macaques Chronically Infected with a Live Attenuated Simian Immunodeficiency Virus.J Virol2019
29118125ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment.J Virol2018
30224552Preexisting Simian Immunodeficiency Virus Infection Increases Susceptibility to Tuberculosis in Mauritian Cynomolgus Macaques.Infect Immun2018
30111562Acute-Phase CD4<sup>+</sup> T Cell Responses Targeting Invariant Viral Regions Are Associated with Control of Live Attenuated Simian Immunodeficiency Virus.J Virol2018
28115506Characterization of T Cells Specific for CFP-10 and ESAT-6 in Mycobacterium tuberculosis-Infected Mauritian Cynomolgus Macaques.Infect Immun2017
25977790A comprehensive collection of systems biology data characterizing the host response to viral infection.Sci Data2014
23935999A network integration approach to predict conserved regulators related to pathogenicity of influenza and SARS-CoV respiratory viruses.PLoS One2013
21865398Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus.J Virol2011
20375168Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.J Virol2010
20668090Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.J Virol2010
  • 1 - 25 of 25

Recommended Authors

Deepashri Rao
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2018
Number of shared co-authors 0
Xiaoyu Luo
Gladstone Institutes, University of California san francisco
Career Start Year 2014
Number of shared co-authors 0
Blake Frey
University of Alabama at Birmingham
Career Start Year 2014
Number of shared co-authors 0
Erik Van Dis
University of California berkeley
Career Start Year 2014
Number of shared co-authors 1
Louise E Hogan
University of California San Francisco
Career Start Year 2012
Number of shared co-authors 0
Chi N Chan
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 2
Vivek Naranbhai
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2006
Number of shared co-authors 0
Kristina De Paris
University of North Carolina at Chapel Hill Chapel Hill
Career Start Year 2004
Number of shared co-authors 1
Claudia T Flynn
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 0
Viraj Kulkarni
Texas Biomedical Research Institute
Career Start Year 2004
Number of shared co-authors 0
Cherie T Ng
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 0
Afam A Okoye
Vaccine & Gene Therapy Institute, and Oregon National Primate Research Center
Career Start Year 2003
Number of shared co-authors 0
Jennifer M Lund
Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 7
Timothy J Henrich
University of California san francisco
Career Start Year 2002
Number of shared co-authors 1
Jacob D Estes
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 1
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 1
Jason M Brenchley
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2000
Number of shared co-authors 0
Maudi Killian
University of California San Francisco
Career Start Year 1999
Number of shared co-authors 0
Stephen A Migueles
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 0
Ulf Dittmer
University Hospital Essen, University of Duisburg-Essen, Institute for Virology
Career Start Year 1993
Number of shared co-authors 0
Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 0
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 1
Mark Connors
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 0
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 0
Bruce D Walker
Ragon Institute of Mass General
Career Start Year 1987
Number of shared co-authors 0
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 5
Louis J Picker
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 7
Jeffrey D Lifson
Frederick National Laboratory
Career Start Year 1977
Number of shared co-authors 2
Ruth M Ruprecht
University of Texas San Antonio
Career Start Year 1971
Number of shared co-authors 0
Luis J Montaner
Wistar Institute
Career Start Year 1958
Number of shared co-authors 0

Collaborators

Jean Chang
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 3
Alexander G White
Co-authored papers 3
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Co-authored papers 3
Katrina M Waters
Pacific Northwest National Laboratory
Co-authored papers 3
Chengjun Li
Harbin Veterinary Research Institute
Co-authored papers 3
Gabriele Neumann
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers 3
Michael G Katze
University of Washington
Co-authored papers 3
Amie J Eisfeld
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers 3
Richard D Smith
Pacific Northwest National Laboratory
Co-authored papers 2
JoAnne L Flynn
Co-authored papers 2
Laurence Josset
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Co-authored papers 2
Anil K Shukla
Pacific Northwest National Laboratory
Co-authored papers 2
Sophia Jeng
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Athena A Schepmoes
Pacific Northwest National Laboratory
Co-authored papers 2
Ralph S Baric
University of North Carolina
Co-authored papers 2
Thomas O Metz
Pacific Northwest National Laboratory
Co-authored papers 2
Robert A Heegel
Pacific Northwest National Laboratory
Co-authored papers 2
Melissa M Matzke
Pacific Northwest National Laboratory
Co-authored papers 2
Brandon F Keele
Co-authored papers 2
Armand Bankhead
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 2
Hugh D Mitchell
Pacific Northwest National Laboratory (PNNL)
Co-authored papers 2
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 2
Maria L Luna
Pacific Northwest National Laboratory
Co-authored papers 2
G Lynn Law
University of Washington, USA Washington National Primate Research Center
Co-authored papers 2
David H O'Connor
Co-authored papers 2
Amy C Sims
The University of North Carolina at Chapel Hill
Co-authored papers 2
Susan C Tilton
Oregon State University
Co-authored papers 2
Nicolas Tchitchek
Sorbonne University INSERM
Co-authored papers 2
Jason E McDermott
Pacific Northwest National Laboratory
Co-authored papers 2
Bobbie-Jo M Webb-Robertson
Pacific Northwest National Laboratory
Co-authored papers 2
Release 1.2